Asia Pacific Respiratory Devices Market Size, Share - Growth Analysis Report and Forecast Trends 2026-2030

The Asia Pacific respiratory devices market encompasses therapeutic, monitoring and consumable products used in hospitals, clinics and home-care settings to manage chronic respiratory diseases, sleep-disordered breathing and acute respiratory failure. The region is the second-largest respiratory devices market globally and is expanding faster than mature Western markets due to its large patient base and improving access to care. Demand spans both established high-acuity equipment such as mechanical ventilators and high-growth consumer-oriented products such as CPAP devices, portable oxygen concentrators and smart inhalers.

• •Estimated 2025 market value: approximately $17.58 billion
• •Forecast CAGR of about 12.64%, outpacing global respiratory device growth
• •Coverage spans China, Japan, India, Australia, South Korea, Southeast Asia and the rest of Asia Pacific

Rising disease burden is the principal engine of growth: COPD, asthma, tuberculosis and obstructive sleep apnea are becoming more prevalent, while air pollution and high smoking rates in parts of the region continue to damage lung health. Demographic aging, particularly in Japan, China and South Korea, is increasing the pool of patients who require long-term respiratory support. Greater investment in hospital capacity, ICU beds and home healthcare, alongside expanding medical insurance coverage in emerging Asian economies, is improving access to respiratory technologies.

• •Increasing incidence of COPD, asthma, OSA and post-infectious lung complications
• •Rapid population aging in North Asia and a growing middle class across Southeast Asia
• •Government and private investment in hospital infrastructure, ICU capacity and home-based care

The market is typically segmented by device type into therapeutic devices (ventilators, PAP machines, nebulizers, oxygen concentrators, inhalers), monitoring devices (pulse oximeters, capnographs, spirometers), and consumables and accessories (masks, circuits, filters, humidifiers). Therapeutic devices account for the largest revenue share, while digital and connected respiratory devices represent the fastest-growing sub-segment. Geographically, China and Japan dominate the regional market, followed by India and Australia, with Southeast Asian countries such as Indonesia, Vietnam and Thailand showing the strongest growth rates.

• •Therapeutic devices lead revenue; digital respiratory devices are growing above 25% annually in some forecasts
• •China and Japan together hold the majority of regional revenue, with India the fastest-growing major market
• •PAP devices, ventilators, oxygen concentrators and smart inhalers are the most commercially important product categories

What are the recent trends and outlook?

The most prominent trend is the rapid digitalization of respiratory care, with connected CPAP machines, smart inhalers and Bluetooth-enabled oxygen devices enabling remote monitoring and data-driven therapy adjustments. Home-based and ambulatory care models are expanding as payers and providers seek to reduce hospital admissions, while integration with telemedicine platforms is accelerating. Over the forecast horizon, AI-assisted ventilation, wearable respiratory monitoring and expanded reimbursement for sleep apnea therapy are expected to further support double-digit growth across the region.

• •Connected and AI-enabled respiratory devices are the fastest-growing innovation area
• •Shift from hospital-centric care to home-based and remote-monitored respiratory therapy is accelerating
• •Strong outlook through 2030, supported by aging populations, rising disease prevalence and digital health adoption across Asia Pacific